Backgroud: Heterotopic pancreas (HP), a relatively uncommon congenital anomaly, is rarely noted during 18 F-FDG positronemission tomography/computed tomography (PET/CT) scan.
Introduction
Heterotopic pancreas (HP) is a relatively uncommon congenital anomaly that is defined as pancreatic tissue without real anatomical or vascular connection to the pancreas. [1, 2] Among all abdominal surgeries, the incidence of heterotopic pancreas ranges from 0.25% to 1.2%. [3, 4] The most frequent locations are the duodenum (9%-36%), stomach (24%-38%), jejunum (0.5%-27%), and Meckel's diverticulum (2%-6.5%), [4, 5] but it can also be found in the ileum, colon, gall bladder, umbilicus, fallopian tube, mediastinum, spleen, and liver. [3] This article reported a case of increased 18 F-FDG uptake of heterotopic pancreatitis in the small intestine on 18 F-FDG PET/CT.
Case report
A 60-year-old woman was referred to our hospital due to a 10-day history of abdominal pain with elevated levels of serum amylase (431 U/L; reference range, 0-108 U/L) and lipase (627 U/ L; reference range, 23-300 U/L). Abdominal CT and ultrasound examinations were negative. In order to search for the cause, an 18 F-FDG PET/CT whole body scan was performed after the injection of 222 MBq (7 mCi) of 18 F-FDG with a blood glucose level of 5.3 mmol/L. The maximum intensity projection PET image (Fig. 1A) revealed a focal increased 18 F-FDG uptake lesion (arrow) and normal 18 F-FDG uptake of the pancreas. Transverse CT (Fig. 1B) , and corresponding PET (Fig. 1C) and fusion ( Fig. 1D ) images showed the lesion (thin arrow) with the SUV max (maximum standardized uptake value) of 4.3 in the small intestine. Then, complete resection of the lesion was performed and abdominal pain disappeared. Low-magnification images ( Fig. 2A A written informed consent for the case report was obtained from the patient. The consent procedure was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Discussion
HP can induce complications including inflammation, ulceration, chemical irritation, bleeding, obstruction, malignant transformation, jejunal intussusception, and ileus. [6] [7] [8] [9] [10] Surgical excision is the first and best choice of treatment because medical treatment is Editor: Saad Zakko.
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The authors have no conflicts of interest to disclose. not effective. [6, 10] However, the preoperative diagnosis of HP in the small intestine is difficult. Symptoms depend on the size of lesion and involvement of mucosa. [10] HP can frequently be mistaken as gastrointestinal stromal tumor or leiomyoma at endoscopy, ultrasonography, or CT scanning. [10, 11] To our knowledge, HP with increased 18 F-FDG accumulation has only been reported in 2 reports with the lesions in the stomach with the SUV max of 4.0 [12] and esophagus with the SUV max of 10.0, which was concerned for a neoplasm before surgery. [13] However, the lesion with increased 18 F-FDG accumulation in small intestine has not been reported before. As the inflammatory behavior of HP is similar to acute pancreatitis or focal exacerbation of chronic pancreatitis which occurs in the normal pancreatic gland, [14] [15] [16] [17] [18] increased 18 F-FDG uptake in HP can be explained. [19] [20] [21] [22] [23] Notably, a high glucose metabolic activity in pancreatic tissues cannot distinguish neoplasm from inflammation. [24] The PET/CT finding with the noted 18 F-FDG uptake in this case likely represented a localized inflammatory process, in accordance with the patient's symptomatology and the relatively low SUV max of 4.3.
In conclusion, this case indicated that heterotopic pancreatitis in small intestine with focal 18 F-FDG uptake should be considered when differing from leiomyoma, [25] lymphoma, [26] gastrointestinal stromal tumor, [27] and intestinal tuberculosis. [28] 
